U. of Utah, David Eccles School of Business, United States
55: Strategy and Innovation in the Biopharmaceutical and Health Care Sectors (12847)
Friday, August 9, 2024
08:30 – 11:00 CT (GMT-5/UTC-5)
1442: From R to D II: The Impact of Policies, Platforms and Business Models on R&D Trajectories
Monday, August 12, 2024
11:30 – 13:00 CT (GMT-5/UTC-5)
1442: Disclosure and Strategic Experimentation in Drug Development (12298)
Monday, August 12, 2024
11:30 – 13:00 CT (GMT-5/UTC-5)
1545: Open Books or Trade Secrets? How Firms Reconcile Secrecy and External Invention Sourcing
Monday, August 12, 2024
13:15 – 14:45 CT (GMT-5/UTC-5)
1545: Markets for Trade Secrets (17583)
Monday, August 12, 2024
13:15 – 14:45 CT (GMT-5/UTC-5)